We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGCTU
726
DELISTED
Cartesian Growth Corp III Unit
CGCTU
$1.87M 0.01%
+184,662
New +$1.86M
FLR icon
727
Fluor
FLR
$7.22B
$1.86M 0.01%
+36,273
New +$1.45M
SAGE
728
DELISTED
Sage Therapeutics
SAGE
$1.83M 0.01%
+200,777
New +$1.48M
VOYA icon
729
Voya Financial
VOYA
$8.98B
$1.82M 0.01%
+25,695
New +$1.65M
LZB icon
730
La-Z-Boy
LZB
$1.62B
$1.81M 0.01%
48,800
-700
-1% -$28K
VALU icon
731
Value Line
VALU
$352M
$1.81M 0.01%
46,308
– –
CF icon
732
CF Industries
CF
$18.4B
$1.81M 0.01%
19,655
+1,500
+8% +$128K
MERC icon
733
Mercer International
MERC
$44.7M
$1.8M 0.01%
+515,429
New +$2.13M
CEE
734
Central and Eastern Europe Fund
CEE
$135M
$1.8M 0.01%
116,000
-500
-0.4% -$7.37K
GRAL
735
GRAIL Inc
GRAL
$2.87B
$1.78M 0.01%
34,689
+3,379
+11% +$122K
SOC icon
736
Sable Offshore Corp
SOC
$843M
$1.78M 0.01%
+80,998
New +$1.88M
NOV icon
737
NOV
NOV
$7.35B
$1.78M 0.01%
143,214
+85,214
+147% +$1.07M
BIIB icon
738
Biogen
BIIB
$29.5B
$1.77M 0.01%
14,100
– –
LDOS icon
739
Leidos
LDOS
$14.5B
$1.76M 0.01%
11,142
– –
PVBC
740
DELISTED
Provident Bancorp
PVBC
$1.76M 0.01%
+140,711
New +$1.6M
NVGS icon
741
Navigator Holdings
NVGS
$1.34B
$1.75M 0.01%
124,000
– –
MELI icon
742
Mercado Libre
MELI
$92.3B
$1.75M 0.01%
+671
New +$1.57M
ATRO icon
743
Astronics
ATRO
$3.47B
$1.75M 0.01%
62,791
-6,000
-9% -$140K
BASE
744
DELISTED
Couchbase
BASE
$1.75M 0.01%
+71,617
New +$1.3M
HTZ icon
745
Hertz
HTZ
$632M
$1.72M 0.01%
252,000
+42,500
+20% +$265K
BRX icon
746
Brixmor Property Group
BRX
$9.93B
$1.7M 0.01%
+65,474
New +$1.66M
ADP icon
747
Automatic Data Processing
ADP
$102B
$1.7M 0.01%
5,500
– –
MYRG icon
748
MYR Group
MYRG
$5.75B
$1.7M 0.01%
+9,347
New +$1.37M
SHG icon
749
Shinhan Financial Group
SHG
$33.6B
$1.69M 0.01%
37,400
+750
+2% +$28.6K
CACC icon
750
Credit Acceptance
CACC
$5.78B
$1.67M 0.01%
3,270
-330
-9% -$162K
28 29
30
31 32

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.